Clene Inc. Profile Avatar - Palmy Investing

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, incl…

Biotechnology
US, Salt Lake City [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Clene Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of CLNN's Analysis
CIK: 1822791 CUSIP: 185634102 ISIN: US1856341029 LEI: - UEI: -
Secondary Listings
CLNN has no secondary listings inside our databases.